All News #Library
Biotech
Eisai`s EA Pharma Starts Phase III Trial For Evenamide
07 Jan 2026 //
PHARMIWEB
Newron Boosts Evenamide IP With EU Patent On `Crystalline Forms`
06 Jan 2026 //
PHARMIWEB
Newron Launches ENIGMA-TRS 2 Phase III Study In US For Evenamide
08 Dec 2025 //
BUSINESSWIRE
Newron To Present Evenamide Schizophrenia Data At (ECNP) Congress
02 Oct 2025 //
BUSINESSWIRE
Newron Preclinical Data: Evenamide May Ease Schizophrenia
11 Aug 2025 //
BUSINESSWIRE
Newron Completes Enrollment of Schizophrenia Patients in Study 008A
29 Dec 2023 //
BUSINESSWIRE

Market Place
Sourcing Support